CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more
Introducing a New Summer Camp Experience for Children in Care: CAMP NAWAPON at Mattawa River Resort Read more
Shoppers Drug Mart to hit record milestone: 103 pharmacy care clinics across Alberta by end of 2024 Read more
The U.S. health care system sends women mixed messages about maternal mental health. Change is needed now Read more